Clinical Trial Update: Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluating dietary supplementation with butyrate in individuals with non-alcoholic fatty liver disease and metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Butyrate dietary supplement (butyrate)

Snippet

Sponsor: University of Bologna | Conditions: NAFLD, Metabolic Syndrome | NA | Status: COMPLETED